The psychobiology of sleep and major depression

Depression and Anxiety

Volumn 14, Issue 1, 2001, Pages 1-2

  Szuba, Martin P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; MONOAMINE; SUBSTANCE P;

DEPRESSION; DRUG MECHANISM; EDITORIAL; ELECTROCONVULSIVE THERAPY; HUMAN; INSOMNIA; MENTAL DISEASE; NEUROENDOCRINOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SLEEP DEPRIVATION; SLEEP DISORDER; SYMPTOMATOLOGY;

EID: 0034873067     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.1040     Document Type: Editorial

References (27)

1. Substance P antagonists: The next breakthrough in treating depression?
2. The past and fugure of cognitive therapy
3. Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: An open pilot trial in medicated and unmedicated patients
4. Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults
5. Does adjunctive lorazepam impair the antidepressant response to nortriptyline in elderly depressed patients?
6. Monoamine dysfunction and the pathophysiology and treatment of depression
7. Epidemiologic study of sleep disturbances and psychiatric disorders
8. Sleep disturbances and mood disorders: An epidemiological perspective
9. Sleep deprivation as a model experimental antidepressant treatment: Findings from functional brain imaging
10. Sleep and biological rhythms
11. Frequency of symptoms ill melancholia (depressive illness)
12. Physiological and neurobehavioral effects of sleep loss
13. Sleep research in depressive illness: Clinical implications-a tasting menu
14. Treatment of insomnia in patients with mood disorders
15. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: Laboratory and clinical studies
16. Disturbance of the 24 hour rhythm in endogenous depression and treatment of endogenous depression by sleep deprivation
17. Sleep therapies for depression and potential mechanisms
18. Lithium sustains the acute antidepressant effects of sleep deprivation: Preliminary findings from a controlled study
19. Effects of partial sleep deprivation on the diurnal variation of mood and motor activity in major depression
20. Electroconvulsive therapy increases circadian amplitude and lowers core body temperature in depressed subjects
21. Abnormalities in sleep and brain function in refractory mood disorders
22. Nefazodone and REM sleep: How do antidepressant drugs decrease REM sleep?
23. REM sleep reduction effects on depression syndromes
24. Depression, sleep physiology, and antidepressant drugs
25. Sleep deprivation in depression: What do we know, where do we go?
26. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone
27. The biological basis of an antidepressant response to sleep deprivation and relapse: Review and hypothesis